OUS Approvals Analysis: Summer Brings Slowdown In CE Marks
Executive Summary
Medtech Insight’s new Approvals Tracker recorded 18 approvals outside the US, including five in vitro diagnostic approvals and five cardiovascular device approvals.
You may also be interested in...
US Approvals Analysis: July A Good Month For PMAs; 510(k)s Down In 2016
A look at Medtech Insight's Approval Tracker data shows that last month was a relatively active one for US FDA approvals of novel devices via the PMA, panel-track supplement and de novo routes. But 510(k) clearance totals are down so far in 2016 compared to recent years.
US Approvals Analysis: July A Good Month For PMAs; 510(k)s Down In 2016
A look at Medtech Insight's Approval Tracker data shows that last month was a relatively active one for US FDA approvals of novel devices via the PMA, panel-track supplement and de novo routes. But 510(k) clearance totals are down so far in 2016 compared to recent years.
Pixium's IRIS II CE Mark Stokes Retinal Implant Rivalry
Competition in the retinal implant market heats up as Pixium CE marks its second-generation bionic vision system, designed to offer key advantages including higher resolution and explantability.